Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-05-26 11:57 am Unchanged |
2022-05-25 | 13D | IO Biotech, Inc. IOBT |
Novo Holdings A/S | 3,277,932 11.300% |
0 (Unchanged) |
Filing History |
| 2022-05-11 2:57 pm Sale |
2022-05-05 | 13D | Checkmate Pharmaceuticals, Inc. CMPI |
Novo Holdings A/S | 1,828,484 8.300% |
-341,616 (-15.74%) |
Filing History |
| 2022-05-02 1:52 pm Sale |
2022-04-26 | 13D | Nkarta, Inc. NKTX |
Novo Holdings A/S | 2,238,309 6.700% |
-555,556 (-19.88%) |
Filing History |
| 2022-04-08 2:49 pm Sale |
2022-03-31 | 13D | Mirum Pharmaceuticals, Inc. MIRM |
Novo Holdings A/S | 2,200,000 6.900% |
-245,147 (-10.03%) |
Filing History |
| 2022-02-22 2:11 pm Sale |
2022-02-17 | 13D | Morphic Holding, Inc. MORF |
Novo Holdings A/S | 1,845,030 4.900% |
-205,416 (-10.02%) |
Filing History |
| 2022-02-09 5:18 pm Purchase |
2022-02-03 | 13G | Arcellx, Inc. ACLX |
Novo Holdings A/S | 4,016,878 11.400% |
4,016,878 (New Position) |
Filing History |
| 2022-02-02 5:00 pm Purchase |
2021-12-31 | 13G | Exscientia plc EXAI |
Novo Holdings A/S | 13,086,600 11.000% |
13,086,600 (New Position) |
Filing History |
| 2022-02-02 4:57 pm Purchase |
2021-12-31 | 13G | Evotec SE EVO |
Novo Holdings A/S | 17,894,807 10.200% |
17,894,807 (New Position) |
Filing History |
| 2022-02-02 4:55 pm Sale |
2021-12-31 | 13G | Galera Therapeutics, Inc. GRTX |
Novo Holdings A/S | 2,459,021 9.300% |
-500,000 (-16.90%) |
Filing History |
| 2022-01-31 4:28 pm Sale |
2022-01-28 | 13D | Aligos Therapeutics, Inc. ALGS |
Novo Holdings A/S | 78,000 4.900% |
-26,583 (-25.42%) |
Filing History |
| 2022-01-27 3:31 pm Unchanged |
2022-01-20 | 13D | Reneo Pharmaceuticals, Inc. RPHM |
Novo Holdings A/S | 343,038 14.000% |
0 (Unchanged) |
Filing History |
| 2021-12-20 1:00 pm Unchanged |
2021-12-15 | 13D | CYTEIR THERAPEUTICS INC CYTT |
Novo Holdings A/S | 4,840,413 13.600% |
0 (Unchanged) |
Filing History |
| 2021-11-22 4:08 pm Unchanged |
2021-11-08 | 13D | Spruce Biosciences, Inc. SPRB |
Novo Holdings A/S | 4,514,336 19.200% |
0 (Unchanged) |
Filing History |
| 2021-11-22 4:06 pm Unchanged |
2021-11-08 | 13D | Nkarta, Inc. NKTX |
Novo Holdings A/S | 2,793,865 8.500% |
0 (Unchanged) |
Filing History |
| 2021-11-22 4:03 pm Unchanged |
2021-11-15 | 13D | Bolt Biotherapeutics, Inc. BOLT |
Novo Holdings A/S | 4,503,991 12.000% |
0 (Unchanged) |
Filing History |
| 2021-11-10 4:43 pm Purchase |
2021-11-04 | 13D | IO Biotech, Inc. IOBT |
Novo Holdings A/S | 3,277,932 11.800% |
3,277,932 (New Position) |
Filing History |
| 2021-11-02 4:32 pm Sale |
2021-11-01 | 13G | Freeline Therapeutics Holdings plc FRLN |
Novo Holdings A/S | 119,038 4.990% |
-38,378 (-24.38%) |
Filing History |
| 2021-11-01 4:03 pm Unchanged |
2021-11-01 | 13D | Checkmate Pharmaceuticals, Inc. CMPI |
Novo Holdings A/S | 2,170,100 10.000% |
0 (Unchanged) |
Filing History |
| 2021-11-01 4:00 pm Unchanged |
2021-11-01 | 13D | Morphic Holding, Inc. MORF |
Novo Holdings A/S | 2,050,446 5.600% |
0 (Unchanged) |
Filing History |
| 2021-10-27 4:02 pm Purchase |
2021-10-21 | 13G | Minerva Surgical, Inc. UTRS |
Novo Holdings A/S | 102,857 7.200% |
102,857 (New Position) |
Filing History |